In vivo assessment of GABAergic inhibition and glutamate facilitation in treatment-resistant schizophrenia: a TMS study integrating clinical, cognitive, and neurophysiological evaluations.

Schizophrenia (Heidelb) · 2025 · PMC12179267 · PMID 40537471

Europe PMC DOI

hedged sentences

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

showed a trendp = 0.073so close (0.05 < p ≤ 0.1)

Additionally, non-TRS patients also showed a trend toward higher mean SICI values compared to healthy controls ( p = 0.073).

also in 53,322 other papers

did not reach statistical significancep = 0.053so close (0.05 < p ≤ 0.1)

approached significanceno p-value reported

Although the ISI × group interaction did not reach statistical significance ( F 2,48 = 3.131, p = 0.053), it approached significance.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.